higher AIx (31.1% vs. 27.4% g/m 2 , p=0.05). On the contrary, hypertensives with GFR<60 ml/min/1.73m 2 had similar 10-year cardiovascular risk compared to hypertensives with GFR≥60 ml/min/1.73m 2 (17.3% vs. 13.0%, p=0.323). Conclusions: Renal dysfunction is associated with LVMI and arterial stiffness. Hypertensives with moderate to severe renal dysfunction despite having similar 10-year cardiovascular risk with hypertensives with normal renal function or mild renal dysfunction, demonstrate higher aortic stiffness and LV mass, implying a possible underestimation of risk by Framingham. Thus, measurement of aortic stiffness and LV mass could improve risk stratification in hypertensives with renal dysfunction. Purpose: Primary prevention risk estimation scores such as Framingham Risk Score (FRS) and SCORE may underestimate the risk of coronary artery disease (CAD) in young women. Relatively low prevalence, often delayed diagnosis due to non-typical symptoms, and potentially devastating social consequences of acute coronary disease underlay the importance of improved risk prediction within this particular group of patients. Recent data suggest that postmenopause, and particularly its early stage may be an additional risk factor for premature coronary disease in women. Therefore, we evaluated whether addition of the early versus the late stage of menopausal period to the traditional risk scales impact their predictive value. Methods: A single center case-control study including 323 subjects (mean age 49.42 years) with coronary disease onset (either CAD confirmed by coronary angiography or troponin-positive acute coronary syndrome) before the age of 55, and 347 age matched healthy controls (mean age 49.49 years) from the National Health Survey WOBASZ study. FRS and SCORE were calculated for each of the patients and controls. Area under ROC curve (AUC) was compared between the models containing the combinations of either FRS or SCORE with either early or late postmenopausal period defined respectively as ≤ and >3 years from its onset. Results: Both, early and late stage of postmenopause were more frequent in the group of patients with CAD than in the controls: 128 (39.6%) vs 59 (17.0%); p<0.001, and 97 (54.2%) vs 82 (45.8%); p<0.001, respectively, but the difference in late menopausal stage was slighter. Median of FRS for patients versus controls was 5 vs 3 points respectively, and median of SCORE was 0.96% vs 0.57% respectively. The AUC for FRS was 0,678 and increased significantly after adding early stage of postmenopause to AUC=0.726; p=0,0015. In contrast, after adding late stage of postmenopause the AUC remained constant (AUC=0.678). AUC estimated for SCORE was 0.659 and also increased significantly after adding early stage of postmenopause to AUC=0.721 (p=0.0001). After addition of late stage of postmenopause, AUC did not change (AUC=0.653; p=0.41).
Introduction: Serum uric acid (SUA) is associated with cardiovascular disease (CVD). However, its role in subclinical atherosclerotic diseases is less well known. This study thus aims to explore the role that SUA plays in patients with subclinical atherosclerotic diseases to investigate its potential contribution to cardiovascular risk stratification in these patients for the purpose of primary prevention. Method: Study subjects were recruited through a community health check program. Those with overt CVD or pre-existing CVD risk factors were excluded. Furthermore, all subjects received blood test, vascular surrogate markers of atherosclerosis, including brachial flow mediated dilatation (FMD), pulse wave velocity (PWV), carotid intima media thickness (IMT). The SUA level was categorised into 2 groups (normouricaemia and hyperuricaemia). In male, hyperuricaemia is defined as a SUA level >400 μmol/L, whereas in female it is defined as a SUA level >360 μmol/L. Results: 232 subjects (age=58±11, male=50%) with subclinical CAD were selected. For the whole population, subjects with hyperuricaemia had impaired FMD (4.2±3.0% vs. 6.0±4.3%, P<0.01), greater IMT (0.88±0.14cm vs. 0.83±0.16cm, P=0.03) and PWV (0.99±0.34ms-1 vs. 0.88±0.26ms-1, P=0.03) compared with the normouricaemia group.
In female group (age=58±10), subjects with hyperuricaemia had impaired FMD (3.5±3.2% vs. 6.2±4.8%, P<0.01), PWV (1.01±0.34ms-1 vs. 0.83±0.21ms-1, P=0.03), and higher IMT (0.84±0.12cm vs. 0.78±0.13cm, P=0.08) compared to those with normouricaemia. Conversely in male group (age=58±10), only impairment of FMD (4.6±2.8% vs. 5.9±3.6%, P=0.08) was seen in subjects with hyperuricaemia compared to those with normouricaemia. IMT (0.85±0.15mm vs. 0.82±0.15mm, P=0.70) and PWV (0.98±0.34ms-1 vs. 0.95±0.31ms-1, P=0.65) were not significantly different as compared to subjects with normouricaemia. Nonetheless, multivariate analysis demonstrated that hyperuricaemia was not independently associated with FMD, IMT and PWV in the whole population, independent female group or male group (p>0.05).
Conclusion:
This study demonstrates that hyperuricaemia in females better correlates with FMD, PWV and IMT as compared with males. Interestingly, recent studies have shown that SUA is more strongly correlated with CVD in women than in men. In both female and male subjects, the independent relationships were nonetheless limited after multivariate adjustments. These results suggested that hyperuricaemia may have a gender-specific, but with limited independent role, in relation to subclinical atherosclerosis.
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Air pollution induces endothelial dysfunction via oxidative stress in myocardial injured rats by isoproterenol W. Kim, K.H. Lee, J.S. Woo, J.B. Kim, W.S. Kim, G.S. Kim, S.J. Kwon, S.J. Hwang. Kyung Hee University Hospital, Seoul, Korea, Republic of Objectives: Air pollution is an environmental health risk factor that is associated with increased cardiovascular morbidity and mortality. Here, we hypothesize that air pollution-mediated oxidative stress induces endothelial dysfunction. Methods: Sprague Dawley Rats were injected with isoproterenol (ISO, 75mg/kg) subcutaneously, once daily, for 2 days. Two weeks after ISO administration, rats were exposed air pollutant in the specially designed car which measured the particulate air pollutants and exposed to animals in traffic areas in Seoul for 19 days, 4 hours a day. Aortic rings were embedded in Matrigel and photographed on day 5 with an inverted microscope. Data were constituted by counting the number of branch points in each image. To understand the role of air pollution to oxidative stress, aorta homogenates were used for in vitro ROS/RNS assay, which detects hydrogen peroxide, peroxylradical and peroxynitrite anion. Malondialdehyde (MDA) and Nitric Oxice (NO) levels were also assessed in aorta homogenates. Results: ISO and concomitants with air pollution exposure impaired availabilities of tube formation in aorta. Total numbers of branch points were reduced by 64% and 79% in ISO-treated and air pollution exposure after ISO-treated groups respectively. ROS in aorta tissue was increased by ISO and ISO+AP by 1.3 and 1.45 fold as compared to no-treat group. In addition, MDA concentration was also increased by ISO and further pollutant exposure (40.883±4.42 in no-treat, 65.15±17.11 in ISO and 74±12.76 nM MDA/mg in ISO+AP). However total NO levels were not changed. Conclusions: Air pollution impairs aorta endothelial function via ROS generation, with NO-independent manner in ISO-treated rats.
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Reduced plasma levels of nitric oxide metabolites in normotensive middle-aged men with electrocardiographically determined left ventricular hypertrophy Purpose: Recent studies have shown that normotensive subjects with electrocardiographically determined Left Ventricular Hypertrophy (ECG-LVH) are at risk of multiple cardiovascular diseases. However, the underlying mechanisms remain to be elucidated. In this study, we tested our hypothesis that normotensive individuals with ECG-LVH have reduced plasma levels of metabolites of Nitric Oxide (NO), a critical regulator of cardiovascular function. Methods: Among 579 Japanese male workers (40-65 years of age) without hypertension [antihypertensive treatment or blood pressure (BP) ≥140/90 mmHg], we finally studied 73 subjects with ECG-LVH and 292 subjects without ECG-LVH who were matched for age, and systolic and diastolic BP. ECG-LVH was determined by the Sokolow-Lyon voltage >38 mm and the Cornell voltage-duration product >2440 mm×ms. Plasma levels of NOx (NO metabolites, nitrite and nitrate) were measured by the Griess method. The subjects were categorized by quartiles of plasma NOx levels, and a logistic regression analysis was conducted relating the prevalence of ECG-LVH to NOx quartiles after adjusting age, waist circumference, and systolic and diastolic BP, and smoking status. Results: Of the clinical characteristics, the subjects with ECG-LVH had lower body mass index, waist circumference, serum triglyceride and fasting insulin levels and higher serum high-density lipoprotein cholesterol levels as compared with the subjects without ECG-LVH (each P<0.05). The median levels of plasma NOx were significantly reduced in the subjects with ECG-LVG as compared with the subjects without ECG-LVH [22.5 (IQR: 15.1-41.0) mmol/l vs. 36.8 (IQR: 25.0-56.2) mmol/l, P<0.05]. In the subgroup analysis, there also was a significant negative correlation between the prevalence rate of ECG-LVH and the NOx quartiles 
